A venture capital firm from California that invests in early and late stages of health care companies that produce novel therapies
The Company invests in seed, early, mid and late stage drug and healthcare companies. It typically invests between $2 and $8 million to start with the aim of investing $10 to $15 million per portfolio company over the life of the company. Its portfolio companies include Maui Greens, Potrero Medical, Qool TherapeuticsQool Therapeutics, PROCEPT BioRobotics and Aerpio Pharmaceuticals.
Kearny Venture Partners is a venture capital firm from CaliforniaCalifornia that invests in early and late stages of health care companies that produce novel therapies. Founded in San Francisco, California by Caley Castelein, it has over $330 million in capital under management.
Kearny Venture Partners is a venture capital firm from California that invests in early and late stages of health care companies that produce novel therapies. Founded in San FranciscoSan Francisco, California by Caley Castelein, it has over $330 million in capital under management.
The Company invests in seed, early, mid and late stage drug and healthcare companies. It typically invests between $2 and $8 million to start with the aim of investing $10 to $15 million per portfolio company over the life of the company. Its portfolio companies include Maui Greens, Potrero Medical, Qool Therapeutics, PROCEPT BioRoboticsPROCEPT BioRobotics and Aerpio Pharmaceuticals.
The Company invests in seed, early, mid and late stage drug and healthcare companies. It typically invests between $2 and $8 million to start with the aim of investing $10 to $15 million per portfolio company over the life of the company. Its portfolio companies include Maui Greens, Potrero MedicalPotrero Medical, Qool Therapeutics, PROCEPT BioRobotics and Aerpio Pharmaceuticals.
A venture capital firm from California that invests in early and late stages of health care companies that produce novel therapies
Kearny Venture Partners is a venture capital firm from California that invests in early and late stages of health care companies that produce novel therapies. Founded in San Francisco, California by Caley Castelein, it has over $330 million in capital under management.
The Company invests in seed, early, mid and late stage drug and healthcare companies. It typically invests between $2 and $8 million to start with the aim of investing $10 to $15 million per portfolio company over the life of the company. Its portfolio companies include Maui Greens, Potrero Medical, Qool Therapeutics, PROCEPT BioRobotics and Aerpio Pharmaceuticals.